Oric Pharmaceuticals, Inc. Insider Selling: Dominic Piscitelli Trims Stake

A Form 4 filed with the SEC shows Dominic Piscitelli, CFO at Oric Pharmaceuticals, Inc. (ORIC), sold 600 shares of company stock on 2026-09-24.

The transaction was executed at a price of $13.50 per share, for a total value of approximately $8,103.

Under SEC rules, corporate insiders — officers, directors, and holders of more than 10% of a company's shares — are required to report changes in their ownership within two business days of the transaction via Form 4.

Sales by insiders often reflect routine portfolio management or pre-scheduled trading plans rather than a view on the company's prospects.